Please login to the form below

Not currently logged in

WHO set to review Pfizer/BioNTech COVID-19 vaccine for emergency use listing

WHOFollows approval for emergency use in the UK yesterday

US secures 650,000 additional doses of Lilly’s COVID-19 antibody

Eli Lilly new HQThis takes the total purchased amount to 950,000 doses

Novavax moves closer toward launch of US phase 3 COVID-19 vaccine trial

novavaxCompany also completes enrolment in UK-based phase 3 trial

Sanofi Genzyme takes home New Product Introductions Award at PMEA 2020

New Product Introductions winnerWinning entry stood out in a strong category

EMA launches rolling review of J&J’s COVID-19 vaccine

J&J cottonwood driveVaccine entered phase 3 testing in September

Pfizer/BioNTech’s COVID-19 vaccine gets first approval from UK

covidThe UK has already signed a supply deal for 40 million doses

NHS set to pilot GRAIL’s wide-ranging cancer blood test

Interim analysis clinical trialsPrevious study indicates test can detect over 50 cancer types

AZ divests European rights for cholesterol med Crestor to Grünenthal

AZ NEWGrünenthal will pay up to $350m for the rights

Caroline GoslingQ&A: Caroline Gosling

PME interviews Rubica's Director of Culture & Engagement

Latest appointments

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Not waving but drowning. Reflections on data curation in the age of information overload
digital healthcare chronic disease
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
Providers are looking at digital solutions to transform this area of healthcare...
Live webinar:
The power of a good story: Turn your insights into effective storytelling with data visualisation...